Recent News

• 10.03.2025 - Cartesian Therapeutics Announces New Employment Inducement Grant
• 09.10.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.04.2025 - Cantor Global Healthcare Conference 2025
• 08.28.2025 - Cartesian Therapeutics to Participate in Upcoming Investor Conferences
• 08.07.2025 - Cartesian Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
• 08.05.2025 - Cartesian Therapeutics Announces New Employment Inducement Grants
• 07.09.2025 - Martin Fan
• 06.03.2025 - Cartesian Therapeutics Announces New Employment Inducement Grants
• 05.30.2025 - Cartesian Therapeutics Announces First Participant Enrolled in the Phase 3 AURORA Trial of Descartes-08 in Patients with Myasthenia Gravis

Recent Filings

• 08.07.2025 - 8-K Current report
• 08.07.2025 - EX-99.1 EX-99.1
• 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 06.16.2025 - 8-K Current report
• 05.30.2025 - 8-K Current report
• 05.30.2025 - EX-99.1 EX-99.1
• 05.14.2025 - 4 Statement of changes in beneficial ownership of securities